News
GLP-1 Shortage and Supply News
Monitored category — items publish only when newsworthy and sourced.
The shortage-and-supply category tracks official FDA drug-shortage status for GLP-1 products and its implications for compounding. Shortage status is a regulatory determination with dates; we distinguish it clearly from marketing claims about availability.
Category page indexable; items gated. An item appears here only with a primary source and an event date. We would rather show nothing than manufacture freshness.
What we watch in this category
- FDA shortage list additions and resolutions
- Manufacturer supply statements
- Compounding implications of resolved shortages
- Date distinctions between products and doses
Primary sources monitored
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.